GlassScriptPhysician profile
James M Heltzer
NPI 1336171248
$5,048.80
in general payments reported to CMS, 2019-2025
29 companies · $966 in 2025
The $966 reported for 2025 was more than what 76% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $718 · 2020: $995 · 2021: $378 · 2022: $442 · 2023: $847 · 2024: $703 · 2025: $966.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,505 · Travel and Lodging: $10.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,505.46 |
| Travel and Lodging | $10.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $674.40 | 2022-2025 | |
| Alcon Vision LLC | $508.06 | 2019-2025 | Clareon, Hydrus Microstent, Rocklatan |
| New World Medical,INC. | $426.64 | 2020-2025 | Clearpath, Ahmed Glaucoma Valve, Streamline |
| Allergan, INC. | $377.40 | 2019-2022 | |
| Sight Sciences, INC. | $343.69 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Sun Pharmaceutical Industries INC. | $252.12 | 2019-2025 | Cequa |
| Glaukos Corporation | $246.07 | 2024-2025 | Radius, Istent Trabecular Micro-Bypass System Model Is3, Idosetr |
| Aerie Pharmaceuticals, INC. | $244.70 | 2019-2021 | |
| Ivantis, INC | $244.69 | 2019-2020 | |
| Oyster Point Pharma, INC. | $241.81 | 2023-2025 | Tyrvaya, Ryzumvi |
| Bausch & Lomb Americas INC. | $223.70 | 2022-2025 | Envista Mx60 Iol, Ic-8 Apthera Iol, Miebo |
| Biotissue Holdings INC. | $219.86 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $177.69 | 2019-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $128.72 | 2019-2021 | |
| Shire North American Group INC | $122.76 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apellis Pharmaceuticals, INC. | $118.80 | 2023 | Syfovre |
| Rxsight INC | $69.94 | 2022-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Harrow Eye, LLC | $65.02 | 2025 | Vevye |
| Tarsus Pharmaceuticals, INC. | $60.67 | 2024-2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $57.90 | 2019-2021 | |
| Dompe US, INC. | $54.67 | 2025 | Oxervate |
| Regeneron Healthcare Solutions, INC. | $36.84 | 2025 | Eylea Hd |
| Amgen INC. | $31.92 | 2025 | Tepezza |
| Ani Pharmaceuticals, INC. | $25.29 | 2025 | Iluvien |
| Eyepoint US, INC. | $21.29 | 2021 | |
| Astellas Pharma US INC | $20.98 | 2023 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $18.65 | 2024 | Tecnis Iol |
| Thea Pharma INC. | $15.12 | 2024 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Heltzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.